Thomas W. LeBlanc, MD, on Hematologic Malignancies: The Case for Palliative Care

Posted: Tuesday, November 14, 2017

Thomas W. LeBlanc, MD, of Duke Cancer Institute, discusses the support palliative care provides patients and families; the fact that such care can be provided even with curative-intent treatments; and the many studies that show improved patient outcomes when palliative care is added to standard cancer care.